Streetbeat News

Regulatory

ACET

Adicet Bio announced that the FDA has granted Fast Track Designation to ADI-001 for the treatment of relapsed/refractory Class III or Class IV Lupus Nephritis. This designation aims to expedite the development and review of drugs for serious conditions with unmet medical needs.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 11:04 am

BMY

IMAB

I-Mab has entered a clinical collaboration with Bristol Myers Squibb to evaluate the combination of givastomig, an investigational bispecific antibody, with nivolumab and chemotherapy for treating advanced Claudin 18.2-positive gastric and esophageal cancers. The study will be a multi-national Phase 1 trial conducted by I-Mab, with Bristol Myers Squibb supplying nivolumab.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 11:02 am

IMMP

Trading halt status for IMMP was updated at 7:00:00 AM ET. The halt was due to news and resumption times.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 11:00 am

ITRG

Integra Resources announced that the Mine Plan of Operations for the Delamar and Florida Mountain Project has met the content requirements of the US Code of Federal Regulations Title 43 Subpart 3809, as confirmed by the US Bureau of Land Management.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 10:35 am

MNOV

MediciNova has received a Notice of Allowance from the US Patent and Trademark Office for a pending patent application covering MN-166 (Ibudilast) for the prevention of metastasis in various cancers.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 10:02 am

TSLA

Tesla Inc (NASDAQ:TSLA) will halt production for five days in June at its Berlin gigafactory to implement efficiency upgrades. This is the third production halt this year, following an arson attack in March and a one-day shutdown in May due to protests. Despite these interruptions, Tesla plans to expand the factory's capacity significantly.

Portfolio Pulse from Anan Ashraf

June 05, 2024 | 10:02 am

NVX

Trading for NVX has been halted as of 3:58:13 a.m. ET due to pending news. Investors should stay tuned for further updates.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 7:58 am

BLK

ICE

NDAQ

BlackRock and Citadel are leading efforts to establish a new stock exchange in Texas, named the Texas Stock Exchange (TXSE), aiming to challenge the dominance of the NYSE and Nasdaq. The new exchange plans to be more CEO-friendly and apolitical, attracting IPOs and secondary listings. TXSE has secured $120 million in funding and plans to begin trading in 2025.

Portfolio Pulse from Shanthi Rexaline

June 05, 2024 | 6:29 am

GME

Renowned investor Ross Gerber has cautioned Keith Gill, known as 'Roaring Kitty', about his short-term position in GameStop Corp. (NYSE:GME). Gerber's warning follows Gill's disclosure of a $115.7 million stake in GameStop, including $65.7 million in call options expiring on June 21. The revelation has led to a surge in GameStop's stock, but Gerber and others have raised concerns about potential market manipulation.

Portfolio Pulse from Benzinga Neuro

June 05, 2024 | 12:48 am

CNSP

Trading for CNS Pharmaceuticals, Inc. (CNSP) was halted at 7:50:00 p.m. ET pending news. Investors should stay tuned for further updates.

Portfolio Pulse from Benzinga Newsdesk

June 04, 2024 | 11:50 pm